Quick verdict: AMKR vs DOX in 2026

Overall, Amdocs (DOX) holds a significant edge in this amkr vs dox stock comparison 2026, outperforming Amkor (AMKR) across most key financial metrics and analyst sentiment. While AMKR shows stronger current revenue growth, DOX emerges as the clear leader in valuation, profitability margins, and holds a much more favorable outlook from financial analysts and intrinsic valuation models. Investors prioritizing value, strong margins, and significant potential upside may find DOX more appealing, whereas AMKR offers positive, albeit moderate, top-line expansion. Not investment advice.

AMKR vs DOX: key metrics side by side

Full side-by-side comparison of AMKR and DOX across valuation, profitability, growth and analyst sentiment. Data updated 2026-05-11.

AMKR vs DOX valuation comparison

When considering the AMKR vs DOX valuation, Amdocs (DOX) presents a significantly more attractive profile for value-oriented investors. DOX currently trades at a P/E ratio of 12.11x, which is substantially lower than Amkor Technology’s (AMKR) P/E of 43.49x. This suggests that the market is pricing DOX’s earnings at a much more reasonable multiple. Similarly, the price-to-book (P/B) ratio for DOX stands at 2.02x, nearly half of AMKR’s 4.18x, indicating that DOX’s assets are valued more conservatively by the market.

Perhaps the most compelling aspect of DOX’s valuation is its discounted cash flow (DCF) upside, estimated at an impressive +98.4%. In stark contrast, AMKR’s DCF analysis suggests a significant downside of -83.3% from its current price. This wide disparity strongly implies that Amdocs is undervalued based on its intrinsic future cash flow potential, while Amkor appears to be trading well above its fundamental value. Based on these metrics, DOX is clearly the cheaper stock from a valuation perspective, offering a more compelling entry point for investors seeking value in 2026.

AMKR vs DOX growth comparison

In terms of recent top-line expansion, Amkor Technology (AMKR) demonstrates stronger momentum in this AMKR vs DOX growth comparison. AMKR reported a year-over-year revenue growth of 6.2%, indicating a healthy increase in sales. This contrasts sharply with Amdocs Limited (DOX), which experienced a revenue contraction of -9.4% year-over-year. For investors prioritizing current revenue growth rates, AMKR’s positive trajectory makes it the leader in this specific metric.

However, a holistic view of growth also involves efficiency and future prospects. While AMKR shows positive revenue growth, DOX’s superior profitability margins, such as a net margin of 12.49% compared to AMKR’s 6.17%, and an EBITDA margin of 20.76% versus AMKR’s 14.88%, suggest a more efficient operation. Furthermore, the significantly higher analyst price target upside (+41.2%) and DCF upside (+98.4%) for DOX, compared to AMKR’s negative target and DCF downside, could imply stronger anticipated future growth and earnings potential, despite the recent revenue dip for Amdocs.

AMKR vs DOX profitability

When examining AMKR vs DOX profitability, Amdocs Limited (DOX) significantly outperforms Amkor Technology (AMKR) across key margin metrics. DOX boasts a net margin of 12.49%, more than double AMKR’s 6.17%. This indicates that for every dollar of revenue, Amdocs is able to retain considerably more as net income compared to Amkor. Similarly, DOX’s EBITDA margin of 20.76% is notably higher than AMKR’s 14.88%, suggesting greater operational efficiency before accounting for depreciation and amortization.

The gross margin figures further solidify DOX’s superior profitability, with Amdocs achieving an impressive 37.6% compared to Amkor’s 14.43%. While Return on Equity (ROE) is N/A% for both companies based on the provided data, Amdocs’ free cash flow (FCF) yield of 11.01% dramatically surpasses AMKR’s 0.88%. This high FCF yield for DOX demonstrates its exceptional ability to generate cash from its operations, making it a stronger contender for investors focused on cash generation and financial health. Overall, DOX clearly generates more cash and is far more profitable on a per-revenue basis.

Analyst ratings: AMKR vs DOX

A comparison of analyst ratings for AMKR vs DOX reveals a clear preference for Amdocs Limited (DOX). Out of 11 analysts covering DOX, a strong majority of 63.6% have issued a “Buy” rating, leading to a consensus of “Buy” for the stock. Their average price target for DOX is $90, which represents a substantial upside of +41.2% from its current price of $63.75. This strong analyst confidence suggests a positive outlook for DOX’s future performance.

Conversely, analyst sentiment for Amkor Technology (AMKR) is more cautious. With 14 analysts providing coverage, only 42.9% recommend a “Buy,” resulting in a consensus rating of “Hold.” The average price target for AMKR is $66.75, which actually implies a downside of -12.9% from its current price of $76.61. This indicates that the majority of analysts believe AMKR may be fully valued or even overvalued at its current level, recommending a more conservative approach for investors in 2026.

Should I buy AMKR or DOX stock in 2026?

Deciding whether you should buy AMKR or DOX stock in 2026 largely depends on your investment strategy and risk tolerance, as this amkr vs dox stock comparison 2026 highlights distinct profiles. For growth investors who prioritize recent top-line expansion, Amkor Technology (AMKR) might appear more appealing due to its positive year-over-year revenue growth of 6.2%, contrasting with DOX’s -9.4% revenue decline. However, if your growth thesis leans towards future potential indicated by intrinsic value and analyst sentiment, Amdocs (DOX) offers a compelling narrative with a nearly 100% DCF upside and a +41.2% analyst price target.

For value investors, Amdocs (DOX) stands out as the clear winner. Its significantly lower P/E ratio of 12.11x compared to AMKR’s 43.49x, and a P/B ratio of 2.02x versus 4.18x, suggests that DOX is trading at a much more attractive valuation. The substantial DCF upside of +98.4% for DOX further reinforces its potential as an undervalued asset, whereas AMKR’s -83.3% DCF downside implies significant overvaluation. These amkr vs dox fundamentals and valuation points strongly favor Amdocs for those seeking a margin of safety and intrinsic value.

Regarding income, neither AMKR nor DOX are primary choices for dividend-focused investors. Amkor Technology (AMKR) currently offers no dividend (0.0% yield). Amdocs Limited (DOX) provides a token dividend yield of 0.03%, which, while positive, is negligible for a substantial income stream. Therefore, if income generation is a priority, you might want to look at other investment opportunities. This is not investment advice; always conduct your own thorough research before making any investment decisions.

More AMKR and DOX comparisons

AMKR full stock analysis · DOX full stock analysis · All stock comparisons

FAQ: AMKR vs DOX